The biosynthesis of maduramicin a and ,5 in a culture of Actinomadura yunmensis has been studied using 13C,14C and 110 labeled precursors.
ditions can be used to prepare high specific activity 14C and 3H labeled maduramicin for tissue residue studies and radioimmunoassay of maduramicin.
Furthermore, we were interested in establishing the details of the biosynthetic pathways by which maduramicin is formed from simple precursors.
To address this question, we incorporated [1-13C,18O2]-acetate and [1-13C,18O2] propionate in the maduramicin molecule to determine the origin of the oxygen atoms of the resulting doubly labeled maduramicins by high resolution 13C NMR spectroscopy.
Experimental
Organism Actinomadura yumaensis culture NRRL 12515 was used for this work.
Culture Conditions
The ingredients of the seed culture medium used were (in g/liter): Bacto beef extract (3), Bacto Tryptone (5), glucose (10) , Bacto yeast extract (5) and Bacto agar (1) . The seed culture medium (65 ml) was inoculated with I ml of a thawed suspension of A. yumaensis which had been stored at -80°C, and propagated on a shaker bath (100 rpm) at 32°C for 3 days.
Two and a half ml of the inoculum were transferred to each of a series of 250-m1 Erlenmeyer flasks containing 50 ml of the selected media. Three types of fermentation media were used with the following composition (g/liter): Medium A: Glucose (15) , soy peptone (7.5), Mississippi lime CaCO3 (0.5) and NaCl (1); Medium B: Glucose (30), soy flour (15) , Mississippi lime CaCO3 (1) and NaCl (2); Medium C: Glucose (75), soy flour (25), Gamaco CaCO3 (2) and NaCl (2) . All the fermentations were carried out on a rotary shaker at 32°C for 7 days unless stated otherwise.
Isotope-labeled Substrates Sodium [1-13C] acetate, sodium [2-13C] acetate, sodium [1-13C] propionate, sodium [2-13C] propionate and L-[methyl-13C]methionine of 90 atom % 13C, were purchased from Merck Sharp and Dohme Isotopes (St. Louis, MO); sodium [1-14C] acetate (specific radioactivity 59.0 mCi/mmol), sodium [2-14C]-acetate (54.0 mCi/mmol), sodium [1-14C] propionate (58.4 mCi/mmol), sodium [2-14C] propionate (2.5 mCi/mmol) and L-[methyl-14C]methionine (51.4 mCi/mmol) were purchased from New England Nuclear (Boston, MA). Sodium [1-13C,18O2]propionate was prepared from sodium [1-13C] The product showed 97.4 atom % 2H in the C-2 position of the propionate by 1H NMR spectroscopy.
Incorporation of Isotope-labeled Substrates
In order to find the optimal condition for the highest 13C enrichment of maduramicin, 5 uCi of 14C labeled substrate was mixed with the measured unlabeled substrate and added aseptically to each fermentation flask from 0 hour to 72 hours post-inoculation.
After seven days of fermentation at 32°C, the broth volume was adjusted to 50 ml with H2O. A representative 25 ml of fermentation broth was withdrawn into a 250-ml centrifuge bottle, followed by addition of 25 ml of MeOH. After occasional shaking for 1 hour, 25 ml of CH2Cl2 was added, followed by 75 ml of H2O. The bottle was stoppered, shaken for 2 minutes and centrifuged at 850 rpm for 15 minutes. The upper aqueous layer was siphoned and discarded. A 5-ml sample from the remaining CH2Cl2 solution was transferred into a flask and evaporated. The residue was dissolved in 1 ml of the solvent system, 0.1 M NH4OAc (pH 5.0) -MeOH, 8:92, containing di-n-octylphthalate as an internal standard. Then a 40-ul aliquot was injected into an HPLC equipped with a Ultrasphere-ODS column (Altex, 5 um, 4.6 mm x 25 cm). The chromatograph was operated isocratically at a flow rate of 1.5 ml/ minute using the solvent system, 0.1 M NH4OAc (pH 5.0) -McOH, 6.5: 93.5. Detection was achieved by a Water's differential refractometer. The radioactivity of the collected product permitted the calculation of % 14C incorporation of the substrate.
Standard solutions of authentic maduramicin were prepared containing 5 mg/ml of di-n-octylphthalate as internal standard. From the HPLC data of these standard solutions, a standard straight line was plotted and employed to calculate the maduramicin yield of the fermentation.
From the % 14C incorporation data and the fermentation yield, the 13C enrichment in maduramicin was calculated for the proposed biosynthetic precursors.
After the optimal condition was chosen, 13C incorporation was carried out using a mixture of 13C and the corresponding 14C labeled substrate (3-10 uCi) for each of the ten fermentation flasks. At the end of the fermentation, a small portion of the fermentation broth was assayed by HPLC as described above and the rest was worked up to isolate maduramicin.
Isolation of Maduramicin
The fermentation broth (500 ml) was harvested and the pH was adjusted to 8.0 with sodium bicarbonate, after which it was stirred overnight with an equal volume of EtOAc. After the addition of Celite (28 g) and filtration through a Celite cake, the organic layer was separated and dried over magnesium sulfate. After filtration and evaporation, the residue was dissolved in 10 ml of CHCl3 and chromatographed on a column (1.6 cm x 85 cm) packed with 170 ml of Woelm silica gel. The column was eluted with the following solvent systems consecutively: (1) CHCl3 -EtOAc, 7: 3, 600 ml; (2) CHCl3 -EtOAc 3: 7, 400 ml and (3) EtOAc, 200 ml. Each fraction (50 ml) was checked by TLC on a silica gel plate (E. Merck) in the solvent system EtOAc -CH2Cl2, 7: 3. Detection was made by spraying with 5 % sulfuric acid in methanol, followed by heating with a heat gun. Fractions numbered 4 to 11 were combined and the solvents were removed in vacuo. The residue was recrystallized from ethyl ether -n-hexane to yield 1.4647 g of white crystalline maduramicin sodium a, mp 195 -198°C. Likewise work up of fractions numbered 14 to 19 yielded 0.1120 g of maduramicin sodium B. The % 13C incorporation was determined by 13C NMR spectroscopy using a Bruker CXP 300 spectrometer.
Results and Discussion
Three kinds of fermentation media were tested and their production profiles are shown in Table 1 .
The maduramicin production began approxi- Table 2 . Whereas methionine did not stimulate the maduramicin biosynthesis, acetate at levels up to 1.15 g/liter increased the production of maduramicin. The fermentation was sensitive to early addition of propionate especially in the high glucose medium (Medium C). Even at 0.25 g/liter level, the maduramicin yield was After the fermentation conditions for the best incorporation of substrates had been established, 13C labeled substrates were utilized for incorporation into maduramicin. The results of these runs are summarized in Table 3 (Fig. 4) . In addition, resonances corresponding to C-38, C-39, C-40, C-41, C-42 and C-43 were undisturbed, while resonances from C-3, C-5, C-6, C-7 and C-37 were all shifted, especially the C-5 signal which was shifted upfield by 10.75 ppm (Table 5) . Therefore, in the 3 compound, the methoxy group (60.54 ppm, C-47) on C-5 (in ring A) must be replaced by a hydroxyl group and the resonance of the neighboring methoxy group (C-46) on C-6 shifted to 58.99 ppm. The remaining methoxy groups (C-44 and C-45) in the G ring were then readily assigned, because C-45 was more shielded than C-44.
The complete 13C assignments of maduramicin are listed in Table 4 . The resonances at 79.92 and 82.01 ppm were assigned tentatively to C-24 and C-6, because both carbons were enriched by [2-13C]-acetate. Also they were both methine carbons and unable to be differentiated by DEPT experiment9), in which carbons attached to different numbers of protons can be distinguished. Furthermore, for structurally similar ionophores, C-6 in K-41A was assigned identically with C-24 in mutalomycin at 78.80 ppm10). This ambiguity was resolved by comparing the 13C NMR spectra of maduramicin a and ;°, because one of these two resonances would be appreciably influenced by the replacement of a methoxy group with a hydroxyl group. In the 13C
NMR spectrum of maduramicin 3, the resonance at 82. Acetate Propionate double-quantum 13C NMR study of maduramicin a, in which all of the carbon-carbon connectivities of both the aglycone and the sugar were determined4,11).Taken together these studies fully elucidate the 13C NMR assignments of both maduramicin a and 8, and designates the locations and relative concentrations of radiolabeled atoms incorporated into maduramicin from the substrates studied.
From the data given in Tables 3 and 4 , it can be seen that the aglycone of maduramicin is assembled from eight acetate and seven propionate units while the four 0-methyl carbons are derived from methionine. Neither labeled acetate nor labeled propionate produced detectable amount of enrichment propionate and 18O gas respectively into monensin. A similar study of incorporation of molecular oxygen in monensin was reported by AJAZ and ROBINSON").
Sodium [1-13C,18O2] propionate was added to the fermentation culture and the resulting doubly labeled maduramicin was analyzed by high-resolution, 75.47 MHz 13C NMR using both single pulse and spin-echo techniques17) (Fig. 6) . The signals corresponding to C-3, C-7 and C-9 each appeared as an enhanced pair of signals corresponding to the respective 15O11O and 13C18O species (Scheme 1). As summarized in Table 6 , the observed 18O enrichments deviated slightly from the theoretical maximum of 70%, reflecting varying degrees of oxygen exchange at each site. The peak was too broad to observe the expected doublet. d The signal was only partially resolved due to line-broadening . the tetrahydropyranyl oxygen, 0-7 of the C-13 spiroketal had been shown to be derived from the C-9
propionate unit, the acetate-derived oxygen at 13C was assigned to the tetrahydrofuran moiety, O-9.
A similar distinction was not possible at C-29. However based on the assignment of monensin12), the acetate-derived 18O attached to C-29 in maduramicin appeared to be the hemiketal hydroxyl oxygen.
The signal corresponding to C-1 was too broad to observe the expected doublet, whereas signals for C-17, C-21 and C-23 each appeared as enhanced singlets. In general, spin-echo experiments produced better resolution of the paired signals from 13C18O and "C"O species than did the single pulse experiments.
This is due to the suppression of overlap due to 13C-13C couplings.
Having established that at least seven, probably eight oxygen atoms of maduramicin are derived from the carboxylate oxygens of the carbon-skeleton precursors acetate and propionate (Scheme 1), we turned our attention to speculate the biosynthetic pathways which would allow us to explain all of our established results. Analysis of our incorporation results suggests that maduramicin biosynthesis shares a similar biochemical mechanism.
The first-formed polyfunctional fatty acid would be the all-E-triene 1 (Scheme 2).
The triene 1 presumably undergoes epoxidation by one or more oxidases to give 16R, 17R, 20R, 21R, 24S, 25S-triepoxide 2. Then ring A was formed by the attack of C-7 hydroxyl on the C-3 carbonyl oxygen. The remaining five ether rings might be generated through a cascade of ring closures initiated by the attack of C-9 hydroxyl of 2. This hypothetical sequence would account for the stereochemistry at C-6, C-7, C-16, C-17, C-20, C-21, C-24 and C-25 of maduramicin. Therefore it is likely that three out of a total of seventeen oxygens originate from molecular oxygen and C-6 hydroxyl from water. Hydration at C-22 is thought to be catalyzed by a hydrolase. It is not clear when the glycoside linkage is formed.
Although no sugar-deficient maduramicin was observed in the fermentation broth, the glycoside formation may well be the last step as indicated in the biosynthesis of erythromycin20). However the possibility of glycoside formation before the simultaneous ring closures may not be ruled out. Work is continuing to clarify these complex biochemical mechanisms.
